Product overview
Type
Influenza, seasonal (Trivalent)
Commercial Name
Vaxigrip
Manufacturer
Sanofi Pasteur
Responsible NRA
Agence nationale de sécurité du médicament et des produits de santé
Country
France
URL
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular or Subcutaneous
Shelf Life
12 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 7
Secondary Packaging
Carton of 10 vials (100 doses) [Dimensions 10.6 x 4.7 x 4.9 cm]
Tertiary Packaging
Box 20 cartons (2000 doses) [Dimensions 24.3 x 21.7 x 10.8]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.0004%
Cold Chain Volume
2.4 cm3/dose (in secondary packaging)